Cardiovascular disease associated with the human immunodeficiency virus: an update (Q41751842)

8 October 2017

title

Cardiovascular disease associated with the human immunodeficiency virus: an update (English)

1 reference

8 October 2017

main subject

cardiovascular disease

1 reference

3

Wendy S Post

1 reference

8 October 2017

Thomas S Metkus

1

1 reference

8 October 2017

Todd T Brown

series ordinal

2

1 reference

8 October 2017

publication date

1 November 2014

1 reference

Current treatment options in cardiovascular medicine

8 October 2017

published in

1 reference

8 October 2017

volume

16

1 reference

8 October 2017

issue

11

1 reference

8 October 2017

page(s)

346

1 reference

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Biologic aging, frailty, and age-related disease in chronic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

HIV and coronary heart disease: time for a better understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

HIV infection and the risk of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Associations between HIV infection and subclinical coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

High prevalence of peripheral arterial disease in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

The unique challenges facing HIV-positive patients who smoke cigarettes: HIV viremia, ART adherence, engagement in HIV care, and concurrent substance use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Food insecurity and other poverty indicators among people living with HIV/AIDS: effects on treatment and health outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

HIV provider-patient communication regarding cardiovascular risk: results from the AIDS Treatment for Life International Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Arterial inflammation in patients with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

HIV and risk of venous thromboembolism: a Danish nationwide population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Human immunodeficiency virus: what primary care clinicians need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Factors associated with D-dimer levels in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Progression of carotid intima-media thickness and coronary artery calcium over 6 years in an HIV-infected cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Management of the metabolic effects of HIV and HIV drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

HIV, HAART, and lipoprotein particle concentrations in the Women's Interagency HIV Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Pilot study of pioglitazone and exercise training effects on basal myocardial substrate metabolism and left ventricular function in HIV-positive individuals with metabolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Effects of combined exercise training on immunological, physical and biochemical parameters in individuals with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Adherence to Mediterranean diet is favorably associated with metabolic parameters in HIV-positive patients with the highly active antiretroviral therapy-induced metabolic syndrome and lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

The DASH diet for high blood pressure: from clinical trial to dinner table

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Omega-3 fatty acid therapy reduces triglycerides and interleukin-6 in hypertriglyeridemic HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Omega-3 fatty acids and hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

n-3 fatty acids in patients with multiple cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11936-014-0346-X

21 January 2018

12 December 2020

The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B.

1 reference

12 December 2020

The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals

1 reference

12 December 2020

Severe premature coronary artery disease with protease inhibitors

1 reference

12 December 2020

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

12 December 2020

2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

12 December 2020

10.1007/S11936-014-0346-X

Identifiers

DOI

1 reference

Dimensions Publication ID

8 October 2017

1041909584

0 references

1 reference